LPL Financial
CUE icon

LPL Financial’s Cue Biopharma CUE Stock Holding History

LPL Financial’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-520
Closed -$3.58K – 6238
2026
Q1 		$3.58K Sell
520
-1,026
-66% -$9.57K ﹤0.01% 5953
2025
Q4 		$14.2K Hold
1,546
– – ﹤0.01% 5834
2025
Q3 		$33.3K Sell
1,546
-434
-22% -$10.2K ﹤0.01% 5685
2025
Q2 		$40.5K Buy
1,980
+549
+38% +$11.7K ﹤0.01% 5386
2025
Q1 		$39.1K Hold
1,431
– – ﹤0.01% 5176
2024
Q4 		$46.8K Buy
1,431
+833
+139% +$31.3K ﹤0.01% 5109
2024
Q3 		$13.6K Hold
598
– – ﹤0.01% 5110
2024
Q2 		$22.2K Buy
598
+167
+39% +$8.26K ﹤0.01% 4927
2024
Q1 		$24.4K Hold
431
– – ﹤0.01% 4828
2023
Q4 		$34.1K Buy
431
+79
+22% +$5.65K ﹤0.01% 4695
2023
Q3 		$24.3K Hold
352
– – ﹤0.01% 4596
2023
Q2 		$38.6K Hold
352
– – ﹤0.01% 4456
2023
Q1 		$37.7K Hold
352
– – ﹤0.01% 4348
2022
Q4 		$30.1K Hold
352
– – ﹤0.01% 4328
2022
Q3 		$24K Buy
+352
New +$30.3K ﹤0.01% 4305

Other funds holding CUE

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM

LPL Financial's CUE Position: Q2 2026 in Review

LPL Financial sold out of Cue Biopharma (CUE) in Q2 2026, closing a stake of 520 shares — an estimated $3.58K sold.

LPL Financial first reported a position in CUE in Q3 2022 and held it in 15 quarters. The position peaked at $46.8K in Q4 2024. 49 funds tracked by Wall St. Rank hold CUE as of Q2 2026.

  • LPL Financial reported no remaining Cue Biopharma position as of Q2 2026 after selling out during the quarter.
  • LPL Financial sold 520 Cue Biopharma shares in Q2 2026, an estimated $3.58K.
  • LPL Financial first reported a position in Cue Biopharma in Q3 2022 and held it in 15 quarters.
  • LPL Financial's Cue Biopharma position peaked at $46.8K in Q4 2024.
  • 49 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.